Company news
Billiontoone, Inc. (NASDAQ:BLLN) news
Every Billiontoone, Inc. press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Largest Prospective Study in General-Risk Pregnancies Strengthens Evidence for cfDNA Fetal Risk Assessment as a Primary Screen for Recess...
August 18, 2026
BillionToOne Reports Second Quarter 2026 Results and Reiterates 2026 Revenue Guidance
August 5, 2026
BillionToOne Appoints Ethan Dmitrovsky, MD, as Chief Medical Officer, Oncology, to Lead Medical Strategy for Northstar
July 20, 2026
BillionToOne to Report Second Quarter 2026 Financial Results on August 5, 2026
July 15, 2026
BillionToOne's Northstar Response® Is a Stronger Predictor of Immunotherapy Outcomes Than Standard-of-Care Imaging for Cancer Patients in...
June 29, 2026
BillionToOne to Participate in the William Blair 46th Annual Growth Stock Conference
May 27, 2026
BillionToOne Reports First Quarter 2026 Results and Raises 2026 Revenue Guidance
May 6, 2026
BillionToOne Launches Unity Confirm™: A category-defining test that bridges the gap between screening and invasive diagnostics
May 1, 2026
BillionToOne to Report First Quarter 2026 Financial Results on May 6, 2026
April 15, 2026
BillionToOne Appoints Dr. Allen Chen as Vice President of Medical Affairs and Clinical Development, Oncology
April 2, 2026
BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenue Guidance
March 4, 2026
BillionToOne to Report Fourth Quarter and Full Year 2025 Financial Results on March 4, 2026
February 17, 2026
BillionToOne Expands Northstar Platform with Launch of Two New Add-On Liquid Biopsy Applications for Northstar Select®
February 10, 2026
BillionToOne Announces Dual Launch of UNITY Expanded Red Blood Cell and Platelet Fetal Antigen NIPTs, Extending Its Leadership In Setting...
February 9, 2026
BillionToOne Announces Collaboration with Epic to Expand Prenatal and Oncology Testing Across Healthcare
January 15, 2026
BillionToOne Provides Guidance for 2026
January 12, 2026
BillionToOne Announces Selection of Northstar Select® as the new liquid biopsy test for LC-SCRUM-TRY clinical study at National Cancer Ce...
January 6, 2026
BillionToOne to Participate in the 44th Annual J.P. Morgan Healthcare Conference
December 23, 2025
BillionToOne Appoints Anthony Pagano to Board of Directors as Audit Committee Chair
December 9, 2025
BillionToOne Reports Third Quarter 2025 Results
December 9, 2025
BillionToOne to Report Third Quarter 2025 Financial Results on December 9, 2025
December 2, 2025
BillionToOne Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
November 7, 2025
BillionToOne Announces Pricing of Upsized Initial Public Offering
November 5, 2025
BillionToOne Announces Launch of Initial Public Offering Roadshow
October 29, 2025